Growing community of inventors

Lyngby, Denmark

Claude Bonde

Average Co-Inventor Count = 4.34

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 93

Claude BondeDorthe Kot Engelund (4 patents)Claude BondeSvend Ludvigsen (2 patents)Claude BondeMorten Schlein (2 patents)Claude BondeTine Elisabeth Gottschalk Bøving (2 patents)Claude BondeTina Bjeldskov Pedersen (2 patents)Claude BondeLars Bohn Hansen (1 patent)Claude BondeKristian Tage Hansen (1 patent)Claude BondeLiselotte Bjerre Knudsen (1 patent)Claude BondeBjarne Rønfeldt Nielsen (1 patent)Claude BondeAnne-Mette Lilleøre (1 patent)Claude BondeEjvind Jensen (1 patent)Claude BondeTine Elisabeth Gottschalk BØVING (0 patent)Claude BondeLars Hansen (0 patent)Claude BondeTine Elisabeth Gottschalk Boving (0 patent)Claude BondeClaude Bonde (4 patents)Dorthe Kot EngelundDorthe Kot Engelund (8 patents)Svend LudvigsenSvend Ludvigsen (15 patents)Morten SchleinMorten Schlein (9 patents)Tine Elisabeth Gottschalk BøvingTine Elisabeth Gottschalk Bøving (2 patents)Tina Bjeldskov PedersenTina Bjeldskov Pedersen (2 patents)Lars Bohn HansenLars Bohn Hansen (15 patents)Kristian Tage HansenKristian Tage Hansen (9 patents)Liselotte Bjerre KnudsenLiselotte Bjerre Knudsen (9 patents)Bjarne Rønfeldt NielsenBjarne Rønfeldt Nielsen (4 patents)Anne-Mette LilleøreAnne-Mette Lilleøre (1 patent)Ejvind JensenEjvind Jensen (1 patent)Tine Elisabeth Gottschalk BØVINGTine Elisabeth Gottschalk BØVING (0 patent)Lars HansenLars Hansen (0 patent)Tine Elisabeth Gottschalk BovingTine Elisabeth Gottschalk Boving (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novo Nordisk A/s (4 from 1,777 patents)


4 patents:

1. 8748376 - Stable formulations of peptides

2. 8158583 - Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia

3. 8114833 - Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices

4. 7595293 - Stable pharmaceutical compositions

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…